View in EDS

Should All Breast Cancer Patients with Symptomatic Bone Metastases be Treated with Bisphosphonates? The Case in Support☆☆This debate was presented at the Tenth Annual Conference on ‘The Science and Art of Pain and Symptom Management’ held in Toronto, Canada on 14–15 November, 2003. Your views are welcomed in a letter to the Editor for publication in the correspondence section of the Journal.

Saved in:
Bibliographic Details
Title: Should All Breast Cancer Patients with Symptomatic Bone Metastases be Treated with Bisphosphonates? The Case in Support☆☆This debate was presented at the Tenth Annual Conference on ‘The Science and Art of Pain and Symptom Management’ held in Toronto, Canada on 14–15 November, 2003. Your views are welcomed in a letter to the Editor for publication in the correspondence section of the Journal.
Authors: Clemons, M.1 mark.clemons@sw.ca
Source: Clinical Oncology. Apr2004, Vol. 16 Issue 2, p108. 4p.
Database: Academic Search Ultimate
Description
ISSN:09366555
DOI:10.1016/j.clon.2004.01.004